Share DSM trading with a premium in chemical sector

The Dutch stock DSM is traded with one the highest CAPE-ratios of the chemical companies. Currently the share is now traded at 425 times the past 10 year's average EPS (CAPE / Shiller PE). With this the stock trades way higher than the average US stock of the chemical companies which now costs 7 times the average 10-years EPS.

Core figures US chemical companies


We further see that over the past year the American chemical companies yielded 31 percent higher. They performed worse than the European sector that yielded 31 percent higher. The American sector trades with a CAPE-ratio of 23 and the European sector trades at 522. So it seems there is a correlation with the CAPE-ratio as the risen stocks also have higher CAPE-ratios.

Over the current book year the total revenu from the company based in Heerlen will be 8,55 billion euros (consensus estimates). This is slightly lower than 2019's revenue of 9,01 billion euros.

Historical revenues and results DSM plus estimates 2020

historische koersen Exxon Mobil

The analysts expect for 2020 a net profit of 736 million euros. The majority of the analysts expects for this year a profit per share of 4,28 euros. The PE-ratio therefore is 31,94.

Per share the analysts expect a dividend of 2,44 euros per share. Thus the dividend yield equals 1,78 percent. The average dividend yield of the chemical companies equals a limited 0,37 percent.

Latest estimates around 163 euros

The most recent recommendations for the chemical company are from Barclays , Berenberg and Deutsche Bank .

DSM 's market capitalization is based on the number of outstanding shares around 24,01 billion euros. The DSM stock was the past 12 months quite unstable. Since last December the stock is even 22 percent higher. This year the stock price moved between 82 and 152 euro.

Historical stock prices DSM

fundamental research dsm

Click here for dividend DSM. At 17.01 the stock trades 1,5 percent lower at 136,7 euros. Nieuwsdienst: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.